Pulse Biosciences (PLSE) Common Equity (2015 - 2026)
Pulse Biosciences (PLSE) posted quarterly Common Equity of $80.7 million for Q4 2025, down 29.78% year-over-year from $114.9 million in Q4 2024, and down 12.99% quarter-over-quarter from $92.7 million in Q3 2025.
Pulse Biosciences (PLSE) Common Equity (2015 - 2026) Analysis & Trends
Pulse Biosciences' Common Equity history runs 11 years deep, the most recent figure standing at $80.7 million for Q4 2025.
- In Q4 2025, Common Equity fell 29.78% year-over-year to $80.7 million; the TTM figure through Dec 2025 stood at $80.7 million (down 29.78% YoY), while the FY2025 annual figure was $80.7 million, down 29.78% from the prior year.
- Common Equity for Q4 2025 stood at $80.7 million, down from $92.7 million in the prior quarter.
- The five-year high for Common Equity was $118.5 million in Q1 2025, with the low at -$10.7 million in Q1 2023.
- The 5-year median for Common Equity is $45.9 million (2021), against an average of $51.0 million.
- Peak annual rise in Common Equity reached 2073.31% in 2023, while the deepest fall reached 151.29% in 2023.
- Pulse Biosciences' Common Equity stood at $44.4 million in 2021, then slumped by 105.07% to -$2.2 million in 2022, then surged by 2073.31% to $44.4 million in 2023, then surged by 158.93% to $114.9 million in 2024, then decreased by 29.78% to $80.7 million in 2025.
- Business Quant data shows PLSE's Common Equity at $80.7 million in Q4 2025, $92.7 million in Q3 2025, and $104.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 18.30 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 24.42 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 21.60 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 6.59 Bn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 19.08 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 2.99 Bn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 4.80 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 8.24 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 6.21 Bn |
| 10 | Pulse Biosciences | 3.33 Bn | 3.33 Bn | 161,000.00 | 99.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 99.50 Mn |
| Dec 31, 2025 | 80.66 Mn |
| Sep 30, 2025 | 92.69 Mn |
| Jun 30, 2025 | 104.49 Mn |
| Mar 31, 2025 | 118.45 Mn |
| Dec 31, 2024 | 114.86 Mn |
| Sep 30, 2024 | 79.13 Mn |
| Jun 30, 2024 | 26.97 Mn |
| Mar 31, 2024 | 36.29 Mn |
| Dec 31, 2023 | 44.36 Mn |
| Sep 30, 2023 | 52.15 Mn |
| Jun 30, 2023 | 60.50 Mn |
| Mar 31, 2023 | -10.67 Mn |
| Dec 31, 2022 | -2.25 Mn |
| Sep 30, 2022 | 6.19 Mn |
| Jun 30, 2022 | 23.42 Mn |
| Mar 31, 2022 | 20.80 Mn |
| Dec 31, 2021 | 44.36 Mn |
| Sep 30, 2021 | 47.39 Mn |
| Jun 30, 2021 | 59.75 Mn |